The binding of HnRNPK to DNA can result in the transcriptional control of several cancer genes, including c-Myc, c-Src, and p53 target genes, by recruiting particular transcription factors, chromatin remodelers, and general transcription machinery components to promoters [33–35]. The gene discussed is HNRNPK; the disease is cancer.